| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 53.857.541 $ | 99,59 | 7.794.458 | ||||||
| Novo Nordisk A/S | Novo Nordisk A/S | EC | 670100205 | Long | Börsenkurs (Stufe 1) | 7.010.458 $ | 12,96 | 146.234 | |
| Eli Lilly & Co | Eli Lilly & Co | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 6.863.138 $ | 12,69 | 5.722 | |
| Pfizer Inc | Pfizer Inc | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 3.452.807 $ | 6,38 | 143.389 | |
| Kailera Therapeutics Inc | Kailera Therapeutics Inc | EC | 482931102 | Long | Börsenkurs (Stufe 1) | 3.359.597 $ | 6,21 | 152.501 | |
| Viking Therapeutics Inc | Viking Therapeutics Inc | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 3.167.066 $ | 5,86 | 81.186 | |
| CSPC Pharmaceutical Group Ltd | CSPC Pharmaceutical Group Ltd | EC | HK1093012172 | Long | Börsenkurs (Stufe 1) | 2.876.151 $ | 5,32 | 3.236.000 | |
| Chugai Pharmaceutical Co Ltd | Chugai Pharmaceutical Co Ltd | EC | JP3519400000 | Long | Börsenkurs (Stufe 1) | 2.438.323 $ | 4,51 | 52.600 | |
| Ascletis Pharma Inc | Ascletis Pharma Inc | EC | KYG0520K1094 | Long | Börsenkurs (Stufe 1) | 2.270.345 $ | 4,20 | 1.686.000 | |
| Zealand Pharma A/S | Zealand Pharma A/S | EC | DK0060257814 | Long | Börsenkurs (Stufe 1) | 2.120.529 $ | 3,92 | 47.873 | |
| Amgen Inc | Amgen Inc | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 2.082.190 $ | 3,85 | 5.750 | |
| AstraZeneca PLC | AstraZeneca PLC | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 2.072.736 $ | 3,83 | 10.931 | |
| Hanmi Pharm Co Ltd | Hanmi Pharm Co Ltd | EC | KR7128940004 | Long | Börsenkurs (Stufe 1) | 1.895.007 $ | 3,50 | 7.386 | |
| Structure Therapeutics Inc | Structure Therapeutics Inc | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 1.651.587 $ | 3,05 | 30.773 | |
| Roche Holding AG | Roche Holding AG | EC | CH1499059983 | Long | Börsenkurs (Stufe 1) | 1.638.730 $ | 3,03 | 3.972 | |
| MBX Biosciences Inc | MBX Biosciences Inc | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 1.513.639 $ | 2,80 | 27.421 | |
| UNITED LAB | United Laboratories International Holdings Ltd/The | EC | KYG8813K1085 | Long | Börsenkurs (Stufe 1) | 1.421.116 $ | 2,63 | 1.322.000 | |
| Jiangsu Hengrui Pharmaceutical | Jiangsu Hengrui Pharmaceuticals Co Ltd | EC | CNE100006XS6 | Long | Börsenkurs (Stufe 1) | 1.395.709 $ | 2,58 | 189.200 | |
| Hansoh Pharmaceutical Group Co | Hansoh Pharmaceutical Group Co Ltd | EC | KYG549581067 | Long | Börsenkurs (Stufe 1) | 1.374.855 $ | 2,54 | 364.000 | |
| Innovent Biologics Inc | Innovent Biologics Inc | EC | KYG4818G1010 | Long | Börsenkurs (Stufe 1) | 1.278.951 $ | 2,36 | 126.000 | |
| Gubra A/S | Gubra A/S | EC | DK0062266474 | Long | Börsenkurs (Stufe 1) | 1.013.783 $ | 1,87 | 20.597 | |
| Gilead Sciences Inc | Gilead Sciences Inc | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 938.075 $ | 1,73 | 7.425 | |
| Rhythm Pharmaceuticals Inc | Rhythm Pharmaceuticals Inc | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 884.465 $ | 1,64 | 7.966 | |
| Shionogi & Co Ltd | Shionogi & Co Ltd | EC | JP3347200002 | Long | Börsenkurs (Stufe 1) | 670.973 $ | 1,24 | 39.100 | |
| WaVe Life Sciences Ltd | WaVe Life Sciences Ltd | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 467.310 $ | 0,86 | 80.432 | |
| Gesamt | 53.857.541 $ | 99,59 | 7.794.458 |